- Home
- DOMH vs ELUT Comparison
DOMH vs ELUT Comparison
Compare DOMH & ELUT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | DOMH | ELUT |
|---|---|---|
| Founded | 1967 | 2015 |
| Country | United States | United States |
| Employees | N/A | 26 |
| Industry | Biotechnology: Pharmaceutical Preparations | Medical Specialities |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 55.0M | 45.8M |
| IPO Year | 2010 | 2020 |
Fundamental Metrics
Financial Performance| Metric | DOMH | ELUT |
|---|---|---|
| Price | $2.88 | $1.04 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $6.00 |
| AVG Volume (30 Days) | 95.6K | ★ 157.8K |
| Earning Date | 05-12-2026 | 03-11-2026 |
| Dividend Yield | ★ 21.03% | N/A |
| EPS Growth | 39.75 | ★ 146.77 |
| EPS | ★ 7.86 | 0.87 |
| Revenue | ★ $18,146,000.00 | $12,293,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $10.83 |
| P/E Ratio | ★ $0.39 | $1.23 |
| Revenue Growth | ★ 789.95 | N/A |
| 52 Week Low | $2.76 | $0.50 |
| 52 Week High | $8.40 | $2.99 |
Technical Indicators
Market Signals| Indicator | DOMH | ELUT |
|---|---|---|
| Relative Strength Index (RSI) | 39.02 | 47.72 |
| Support Level | $2.80 | $0.86 |
| Resistance Level | $3.56 | $1.15 |
| Average True Range (ATR) | 0.25 | 0.10 |
| MACD | 0.02 | -0.01 |
| Stochastic Oscillator | 11.33 | 20.00 |
Price Performance
Historical ComparisonAbout DOMH Dominari Holdings Inc.
Dominari Holdings Inc through its various subsidiaries, is currently engaged in wealth management, investment banking, securities sales and trading and asset management. The company operates in two reportable business segments: Dominari Financial and Legacy AIkido. The Dominari Financial reportable business segment represents the Company's broker-dealer business, which is composed of mostly underwriting and transactional service activities. The Legacy AIkido reportable business segment includes Aikido Labs, which manages the investments holdings of the legacy entity. It generates the majority of its revenue from the Dominari Financial segment.
About ELUT Elutia Inc.
Elutia Inc develops proprietary drug-eluting biomatrix products for use in surgical reconstruction and related applications. These products are designed to improve the interaction between implanted medical devices and patients. Its products include CanGaroo, designed for implantable electronic devices, and SimpliDerm, used in soft tissue repair, with functions related to implant support and wound management. The company operates in two segments: Women's Health and Cardiovascular. The majority of revenue is derived from the Women's Health segment.